Pain reliever offers prescribing flexibility

Nov. 1, 1996
UCB Pharma, Inc. has received approval from the U.S. Food and Drug Administration to market Lortab 10/500 CIII (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg, *Warning: May be habit-forming). The new addition to the Lortab brand line of pain relievers offers American doctors the first 10 mg hydrocodone combination, formulated to maximize therapeutic flexibility and minimize the potential for acetaminophen (APAP) toxicity. The 500 mg APAP content is lower than that of any o

UCB Pharma, Inc. has received approval from the U.S. Food and Drug Administration to market Lortab 10/500 CIII (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg, *Warning: May be habit-forming). The new addition to the Lortab brand line of pain relievers offers American doctors the first 10 mg hydrocodone combination, formulated to maximize therapeutic flexibility and minimize the potential for acetaminophen (APAP) toxicity. The 500 mg APAP content is lower than that of any other 10 mg hydrocodone combination. Suggested dosing of one tablet every four to six hours does not exceed the generally recommended, maximum acetaminophen dose of 4000 mg/day. Like other products in the growing Lortab brand line that it complements, Lortab 10/500 provides analgesic relief in minutes that lasts for hours, with onset of action in 10-30 minutes, and duration from four to six hours. The toleration profile is similar to other narcotic analgesics, with light-headedness and sedation among the most frequently reported adverse effects.

For additional information, circle the number below.

UCB PHARMA, INC.

Sponsored Recommendations

Clinical Study: OraCare Reduced Probing Depths 4450% Better than Brushing Alone

Good oral hygiene is essential to preserving gum health. In this study the improvements seen were statistically superior at reducing pocket depth than brushing alone (control ...

Clincial Study: OraCare Proven to Improve Gingival Health by 604% in just a 6 Week Period

A new clinical study reveals how OraCare showed improvement in the whole mouth as bleeding, plaque reduction, interproximal sites, and probing depths were all evaluated. All areas...

Chlorine Dioxide Efficacy Against Pathogens and How it Compares to Chlorhexidine

Explore our library of studies to learn about the historical application of chlorine dioxide, efficacy against pathogens, how it compares to chlorhexidine and more.

Enhancing Your Practice Growth with Chairside Milling

When practice growth and predictability matter...Get more output with less input discover chairside milling.